We are live on ! Find out more
WN

Williams & Novak Portfolio holdings

AUM $151M
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+27.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$134M
AUM Growth
+$782K
Cap. Flow
+$1.48M
Cap. Flow %
1.11%
Top 10 Hldgs %
40.47%
Holding
163
New
22
Increased
48
Reduced
54
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 8.77%
2 Consumer Discretionary 5.94%
3 Communication Services 2.01%
4 Financials 1.47%
5 Healthcare 1.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MINO icon
101
PIMCO Municipal Income Opportunities Active ETF
MINO
$727M
$221K 0.17%
+4,900
New +$223K
VTV icon
102
Vanguard Morningstar Value ETF
VTV
$188B
$216K 0.16%
1,100
ARES icon
103
Ares Management
ARES
$28.1B
$212K 0.16%
+2,000
New +$265K
RAFE icon
104
PIMCO RAFI ESG US ETF
RAFE
$162M
$208K 0.16%
5,000
XOM icon
105
ExxonMobil
XOM
$650B
$207K 0.16%
+1,288
New +$188K
AER icon
106
AerCap
AER
$23.4B
$205K 0.15%
1,463
+63
+5% +$9.01K
UNH icon
107
UnitedHealth
UNH
$382B
$203K 0.15%
741
+19
+3% +$5.66K
TSHA icon
108
Taysha Gene Therapies
TSHA
$1.61B
$194K 0.15%
45,000
HCKT icon
109
Hackett Group
HCKT
$281M
$175K 0.13%
+13,591
New +$217K
ACH
110
Accendra Health
ACH
$254M
$143K 0.11%
57,710
+6,520
+13% +$15K
ERIC icon
111
Ericsson
ERIC
$32.1B
$141K 0.11%
12,283
+1,183
+11% +$12.8K
RGP icon
112
Resources Connection
RGP
$140M
$141K 0.11%
38,530
-12,905
-25% -$52.8K
HBIO icon
113
Harvard Bioscience
HBIO
$27.6M
$138K 0.1%
27,052
-7,828
-22% -$43.8K
RPD icon
114
Rapid7
RPD
$628M
$137K 0.1%
+25,150
New +$231K
III icon
115
Information Services Group
III
$204M
$111K 0.08%
28,886
+4,536
+19% +$22.3K
ADT icon
116
ADT
ADT
$5.43B
$103K 0.08%
15,741
+3,433
+28% +$25.8K
LAW icon
117
CS Disco
LAW
$271M
$83.1K 0.06%
21,858
+6,913
+46% +$34.2K
HFFG icon
118
HF Foods Group
HFFG
$80.7M
$82.7K 0.06%
+40,515
New +$77.5K
XPER icon
119
Xperi
XPER
$364M
$80K 0.06%
14,140
-1,160
-8% -$6.72K
JBI icon
120
Janus International
JBI
$702M
$77.8K 0.06%
15,385
-690
-4% -$4.47K
SSTI icon
121
SoundThinking
SSTI
$108M
$74.7K 0.06%
11,401
-2,874
-20% -$21K
PBYI icon
122
Puma Biotechnology
PBYI
$398M
$71.9K 0.05%
10,639
+79
+0.7% +$509
ARAY icon
123
Accuray
ARAY
$27.5M
$70.8K 0.05%
182,030
+63,175
+53% +$39K
TRIB
124
Trinity Biotech
TRIB
$8.9M
$64.4K 0.05%
3,588
+478
+15% +$10.6K
AVD icon
125
American Vanguard Corp
AVD
$68.7M
$63.6K 0.05%
26,167
-4,063
-13% -$17.3K

Similar funds

Williams & Novak's Q1 2026 Portfolio in Review

As of Q1 2026, Williams & Novak held 163 positions worth $134M, up 0.59% from $133M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Williams & Novak's Q1 2026 filing shows 22 new, 48 increased, 54 reduced and 20 closed positions. Its largest new stake was Salesforce: 11,227 shares worth $2.09M. The largest sale was Fidelity Total Bond ETF, an estimated $2.97M.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, up from 7.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Williams & Novak's largest Q1 2026 buy was Salesforce: 11,227 shares worth $2.09M.
  • Williams & Novak added most to PIMCO Multi Sector Bond Active ETF in Q1 2026, an estimated $1.69M increase.
  • Williams & Novak's biggest Q1 2026 reduction was Fidelity Total Bond ETF, cutting an estimated $2.97M.
  • Williams & Novak fully exited Abbott in Q1 2026, selling an estimated $667K.
  • Williams & Novak's ten largest holdings make up 40% of its $134M portfolio in Q1 2026.
  • Williams & Novak opened 22 new positions and closed 20 in Q1 2026.
  • Williams & Novak's portfolio value rose 0.59% quarter-over-quarter to $134M.

Based on Williams & Novak's 13F filing for Q1 2026, filed 21 Apr 2026.